EPI2ME Labs 23.03-01 Release![Stephen Rudd]()
Our Early March bioinformatics release brings new functionality to the wf-human-variation workflow…
March 08, 2023
2 min
#nextflow 32
An update on our Copy Number Analysis workflow
We have previously shared our standalone workflow for performing copy number analysis. The…
March 08, 2023
1 min
Short Tandem Repeat expansion genotyping in wf-human-variation
Our human variation workflow, wf-human-variation , gives users the ability to call a range of…
March 08, 2023
2 min
EPI2ME Labs 23.02-02 Release![Stephen Rudd]()
Dear Nanopore community, This second bioinformatics release of February includes a new workflow for…
February 22, 2023
1 min
EPI2ME Labs 23.02-01 Release![Stephen Rudd]()
Dear Nanopore Community, This release Wednesday we are pleased to include CNV detection in our human…
February 08, 2023
1 min
EPI2ME Labs 23.01.01 Release![Stephen Rudd]()
Dear Nanopore Community, The EPI2ME Labs application has been updated to revision v4.1.1. This…
January 25, 2023
1 min
Page 1 of 6
Information
© 2020 - 2023 Oxford Nanopore Technologies plc. All rights reserved. Registered Office: Gosling Building, Edmund Halley Road, Oxford Science Park, OX4 4DQ, UK | Registered No. 05386273 | VAT No 336942382. Oxford Nanopore Technologies, the Wheel icon, EPI2ME, Flongle, GridION, Metrichor, MinION, MinIT, MinKNOW, Plongle, PromethION, SmidgION, Ubik and VolTRAX are registered trademarks of Oxford Nanopore Technologies plc in various countries. Oxford Nanopore Technologies products are not intended for use for health assessment or to diagnose, treat, mitigate, cure, or prevent any disease or condition.